Performance and Safety of the Extravascular Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy. - Siontis KC; Murgatroyd F; Boersma LVA; Crozier I; Manlucu J; Knight BP; Leclercq C; Birgersdotter-Green UM; Breitenstein A; Roukoz H; Epstein LM; Wiggenhorn C; et al. (JACC. Clinical electrophysiology, 2026)